Please try another search
PolyNovo Limited develops medical devices in the United States, Australia, New Zealand, the United Kingdom, Ireland, Singapore, and internationally. The company offers NovoSorb Biodegradable Temporising Matrix, which is used in a fully debrided clean surgical wound to physiologically close the wound. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; NovoSorb Dermal Beta Cell Implant to host pancreatic islet cells in the skin; NovoSorb MTX for the treatment of varying complex wounds; and plastics and reconstructive device product. The company was formerly known as Calzada Limited and changed its name to PolyNovo Limited in November 2014. PolyNovo Limited was incorporated in 1998 and is headquartered in Port Melbourne, Australia.
Name | Age | Since | Title |
---|---|---|---|
David John Williams | 57 | 2014 | Independent Non-Executive Chairman |
Leon G. Hoare | - | 2016 | Independent Non-Executive Director |
Robyn Elliott | 61 | 2019 | Independent Non-Executive Director |
Christine Emmanuel-Donnelly | - | 2020 | Independent Non-Executive Director |
Swami Raote | - | 2022 | CEO & Director |
Bruce Rathie | 68 | 2010 | Non-Executive Independent Director |
Andrew Stuart Lumsden | - | 2021 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review